Motif Bio #MTFB and John Meyer on #TSTR #GEO and #BMN

Apr 04, 2018, 12:19 PM

On the Vox Markets Podcast Today - 4th April 2018

Graham Lumsden, CEO of Motif Bio #MTFB discusses the initiation of a new drug application rolling submission for their lead drug Iclaprim to the U.S. FDA and also provides a general business update.

(Interview starts at 1 minute 12 seconds)

John Meyer, Mining analyst and partner at SP Angel talks about: Tri-Star Resources #TSTR, Georgian Mining Corporation #GEO & Bushveld Minerals #BMN

(Interview starts at 7 minutes 33 seconds)

The Top 5 Most Followed Companies on Vox Markets in the last 24 hours & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours.

(Feature starts at 17 minutes 24 seconds)

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast